top of page

Exforge Tablet 10mg/160mg

Product details

Registration number: SIN13418P

Classification: Prescription Only

Active ingredients:

  • Amlodipine besylate 13.87mg (corresponds to amlodipine base)
  • Valsartan

Strength:

  • 10.0mg
  • 160.0mg

Dosage form: TABLET, FILM COATED

Route: ORAL

Registrant: NOVARTIS (SINGAPORE) PTE LTD

ATC code: Not recorded in this imported record.

HSA approval date: 28 February 2008

Manufacturer(s):

  • Siegfried Barbera S.L.
  • Novartis Farma S.p.A.

Manufacturing country/countries: SPAIN; ITALY

What are the HSA registration number and classification for Exforge Tablet 10mg/160mg?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN13418P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Exforge Tablet 10mg/160mg?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • Amlodipine besylate 13.87mg (corresponds to amlodipine base)
  • Valsartan

Strength:

  • 10.0mg
  • 160.0mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Exforge Tablet 10mg/160mg?

According to the HSA dataset updated 7 August 2026:

Dosage form: TABLET, FILM COATED

Route: ORAL

Source for this answer

Who is the recorded registrant for Exforge Tablet 10mg/160mg?

According to the HSA dataset updated 7 August 2026:

Registrant: NOVARTIS (SINGAPORE) PTE LTD

Source for this answer

Which manufacturers and countries are listed for Exforge Tablet 10mg/160mg?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Siegfried Barbera S.L.
  • Novartis Farma S.p.A.

Manufacturing country/countries: SPAIN; ITALY

Source for this answer

Where can I look up Exforge Tablet 10mg/160mg in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN13418P or the exact product name Exforge Tablet 10mg/160mg. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Exforge Tablet 10mg/160mg record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Exforge Tablet 10mg/160mg record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN13418P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page